Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its Exon-4 in mouse uterus

Molecular Carcinogenesis

Volumn 38, Issue 2, 2003, Pages 78-84

  Li, Shuanfang ^a   Hansman, Roberta ^a   Newbold, Retha ^b   Davis, Barbara ^b   McLachlan, John A ^c   Barrett, J Carl ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

c fos gene; DES; Mice uteri

Indexed keywords

DIETHYLSTILBESTROL; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; ENDOMETRIUM; EXON; FEMALE; GENE EXPRESSION; GENE INDUCTION; GENE MUTATION; INTRON; METHYLATION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROMOTER REGION; UTERUS CANCER;

ANIMALS; BASE SEQUENCE; DIETHYLSTILBESTROL; DNA METHYLATION; EXONS; FEMALE; GENE EXPRESSION; GENES, FOS; MICE; PROTO-ONCOGENE PROTEINS C-FOS; UTERUS;

ANIMALIA; VERTEBRATA;

EID: 0141988728     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10147     Document Type: Article

References (36)

1. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284:878-881.
2. Herbst AL, Scully RE, Robboy SJ. Prenatal diethylstilbestrol exposure and human genital tract abnormalities. Natl Cancer Inst Monog 1979;51:25-35.
3. Herbst AL, Ulfelder H, Poskanzer DC, Longo LD. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971. Am J Obstet Gynecol 1999;181:1574-1575.
4. McLachlan JA, Newbold RR, Bullock BC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 1980;40:3988-3999.
5. Newbold RR, Bullock BC, McLachlan JA. Uterine adenocarcinoma in mice following developmental treatment with estrogens: A model for hormonal carcinogenesis. Cancer Res 1990;50:7677-7686.
6. Iguchi T, Takasugi N. Postnatal development of uterine abnormalities in mice exposed to DES in utero. Biol Neonate 1987;52:97-103.
7. Branham WS, Zehr DR, Chen JJ, Sheehan DM. Uterine abnormalities in rats exposed neonatally to diethylstilbestrol, ethynylestradiol, or clomiphene citrate. Toxicology 1988;51:201-212.
8. Medlock KL, Branham WS, Sheehan DM. Long-term effects of postnatal exposure to diethylstilbestrol on uterine estrogen receptor and growth. J Steroid Biochem Mol Biol 1992;42:23-28.
9. Leavitt WW, Evans RW, Hendry WJ III. Etiology of DES-induced uterine tumors in the Syrian hamster. Adv Exp Med Biol 1981;138:63-86.
10. Gilloteaux J, Steggles AW. Endometrium cell surface abnormalities in the Syrian hamster as a result of in utero exposure to diethylstilbestrol. Scand Electron Microsc 1985;(Pt 1): 303-309.
11. Nelson KG, Sakai Y, Eitzman B, Steed T, McLachlan J. Exposure to diethylstilbestrol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. Cell Growth Differ 1994;5:595-606.
12. Kamiya K, Sato T, Nishimura N, Goto Y, Kano K, Iguchi T. Expression of estrogen receptor and proto-oncogene messenger ribonucleic acids in reproductive tracts of neonatally diethylstilbestrol-exposed female mice with or without post-puberal estrogen administration. Exp Clin Endocrinol Diabetes 1996;104:111-122.
13. Falck L, Forsberg JG. Immunohistochemical studies on the expression and estrogen dependency of EGF and its receptor and c-fos proto-oncogene in the uterus and vagina of normal and neonatally estrogen-treated mice. Anat Rec 1996;245:459-471.
14. Yamashita S, Takayanagi A, Shimizu N. Effects of neonatal diethylstilbestrol exposure on c-fos and c-jun protooncogene expression in the mouse uterus. Histol Histopathol 2001;16:131-140.
15. Hebert CD, Endo S, Korach KS, et al. Characterization of murine cell lines from diethylstilbestrol-induced uterine endometrial adenocarcinomas. In Vitro Cell Dev Biol 1992;28A:327-336.
16. Ma L, Benson GV, Lim H, Dey SK, Maas RL. Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in mullerian duct by the synthetic estrogen diethylstilbestrol (DES). Devel Biol 1998;197:141-154.
17. Block K, Kardana A, Igarashi P, Taylor HS. In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system. FASEB J 2000;14:1101-1108.
18. Couse JF, Dixon D, Yates M, et al. Estrogen receptor-α knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract. Dev Biol 2001;238:224-238.
19. Barrett JC, Wong A, McLachlan JA. Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci. Science 1981;212:1402-1404
20. Boyd J, Takahashi H, Waggoner SE, et al. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero. Cancer 1996;77:507-513.
21. Li S, Washburn KA, Moore R, et al. Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res 1997;57:4356-4359.
22. Li S, Ma L, Chiang T, Burow M. Promoter CpG methylatlon of Hox-a10 and Hox-a11 in mouse uterus not altered upon neonatal diethylstilbestrol (DES) exposure. Mol Carcinog 2001;32:213-219.
23. Kim YI, Pogribny IP, Salomon RN, et al. Exon-specific DNA hypomethylation of the p53 gene of rat colon induced by dimethylhydrazine. Modulation by dietary folate. Am J Pathol 1996;149:1129-1137.
24. Li B, Goyal J, Dhar S, et al. CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression. Cancer Res 2001;61:8014-8021.
25. Nguyen TT, Nguyen CT, Gonzales FA, Nichols PW, Yu MC, Jones PA. Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers. Prostate 2000;43:233-242.
26. Nguyen C, Liang G, Nguyen TT, et al. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J Natl Cancer Inst 2001;93:1465-1472.
27. Loose-Mitchell DS, Chiappetta C, Stancel GM. Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol 1988;2:946-951.
28. Jouvenot M, Pellerin I, Alkhalaf M, Marechal G, Royez M, Adessi GL. Effects of 17 beta-estradiol and growth factors on c-fos gene expression in endometrial epithelial cells in primary culture. Mol Cell Endocrinol 1990;72:149-157.
29. Kennedy AR. Is there a critical target gene for the first step in carcinogenesis? Environ Health Perspect 1991;93:199-203.
30. Yoshida A, Newbold RR, Dixon D. Abnormal cell differentiation and p21 expression of endometrial epithelial cells following developmental exposure to diethylstilbestrol (DES). Toxicol Pathol 2002;28:237-245.
31. Hyder SM, Stancel GM, Nawaz Z, McDonnell DP, Loose-Mitchell DS. Identification of an estrogen response element in the 3′-flanking region of the murine c-fos protooncogene. J Biol Chem 1992;267:18047-18054.
32. Hyder SM, Stancel GM. In vitro interaction of uterine estrogen receptor with the estrogen response element present in the 3′-flanking region of the murine c-fos protooncogene. J Steroid Biochem Mol Biol 1994;48:69-79.
33. Hyder SM, Chiappetta C, Stancel GM. The 3′-flanking region of the mouse c-fos gene contains a cluster of GGTCA hormone response-like elements. Mol Biol Rep 1998;25:189-191.
34. Chandrasekhar K, Raman R. De novo methylation of the proto-oncogene, c-fos, during development occurs stepwise and directionally in the laboratory mouse. Mol Reprod Dev 1997;48:421-432.
35. Kanduri C, Raman R. Characterisation of developmentally regulated chromatin structure in the coding region of the proto-oncogene, c-fos, in the male laboratory mouse. Int J Dev Biol 1999;43:279-282.
36. Uehara Y, Ono T, Kurishita A, Kokuryu H, Okada S. Age-dependent and tissue-specific changes of DNA methylation within and around the c-fos gene in mice. Oncogene 1989;4:1023-1028.